Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label DTS-201 monotherapy in hormone-refractory prostate cancer
2007-007727-41Phase 2Active
- Sponsor
- Diatos S.A.
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dts-201 in prostate cancer (PCa), sponsored by Diatos S.A. Primary endpoints: PSA response rate and Safety. Started Mar 2008; status: active.
02
Drugs
dts-201
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2007-007727-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007727-41.